By Brazil Stock Guide – Brazil’s health plan operators are entering the 2026–2027 pricing cycle with a clear message: the era of aggressive post-pandemic price hikes is losing steam.
According to BTG Pactual, the average annual price increase for SME health plans in its sample fell to 10.29% in 2026, down from 13.55% in 2025 and 16.60% in 2024. The deceleration reflects more normalized medical loss ratios across most operators after several years of unusually strong pricing pressure.
The new adjustments cover small-business contracts with up to 30 beneficiaries and apply to the May 2026–April 2027 cycle. Hapvida will raise prices by 9.9%, down from 11.5% last year, while Intermédica, also part of the Hapvida group, will apply a 12.9% increase, down from 15.2%.
Other major operators also showed a slowdown. SulAmérica’s adjustment fell to 11.83% from 15.23%, Bradesco’s to 12.96% from 15.11%, Amil’s to 11.98% from 15.98%, and Unimed Nacional’s to 10.3% from 19.5%.
Unlike individual plans, these small-business contracts are priced directly by operators rather than Brazil’s health regulator, ANS, making them a key signal for broader pricing trends in the sector.
BTG estimates these contracts represent 15% to 20% of total beneficiaries in Brazil’s private healthcare system, and around 17% of Hapvida’s membership base. The trend may also point to softer price dynamics across larger corporate plans.
For investors, the slowdown cuts both ways. Lower price hikes may limit revenue growth, but if accompanied by stable claims, they also reduce the risk of margin pressure.
Leave a Reply